Stockscreener 앱 받기
0.3156
0.06%
-0.0002
시간 외 거래:
.32
0.0044
+1.39%
전일 마감가:
$0.3158
열려 있는:
$0.31
하루 거래량:
158.12K
Relative Volume:
0.12
시가총액:
$13.08M
수익:
$1.50M
순이익/손실:
$-64.59M
주가수익비율:
-0.189
EPS:
-1.67
순현금흐름:
$-55.17M
1주 성능:
+3.14%
1개월 성능:
-0.69%
6개월 성능:
-38.00%
1년 성능:
-85.65%
1일 변동 폭
$0.304
$0.3214
1주일 범위
$0.302
$0.37
52주 변동 폭
$0.2223
$4.79
립 테라퓨틱스 Stock (LPTX) Company Profile
명칭
Leap Therapeutics Inc
전화
617 252 4343
주소
47 THORNDIKE STREET, CAMBRIDGE, MA
LPTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LPTX
Leap Therapeutics Inc
|
0.3156 | 13.51M | 1.50M | -64.59M | -55.17M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
립 테라퓨틱스 Stock (LPTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-29 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-01-29 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-06-28 | 개시 | Rodman & Renshaw | Buy |
| 2021-10-04 | 개시 | Mizuho | Buy |
| 2021-06-04 | 재개 | Robert W. Baird | Outperform |
| 2020-06-29 | 개시 | Piper Sandler | Overweight |
| 2020-02-11 | 개시 | Robert W. Baird | Outperform |
| 2019-11-15 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-09-13 | 재개 | Raymond James | Outperform |
| 2017-03-07 | 개시 | Ladenburg Thalmann | Buy |
모두보기
립 테라퓨틱스 주식(LPTX)의 최신 뉴스
Using R and stats models for Leap Therapeutics Inc. forecastingFree Short Term Buy Zone Stock Alerts - Newser
Is Leap Therapeutics Inc. stock reversal real or fakeSector-Wise Equity Performance Trend Forecast - Newser
Why Leap Therapeutics Inc. stock attracts strong analyst attentionDaily Technical Chart Pattern Analysis Report - Newser
Does Leap Therapeutics Inc. show high probability of reboundDeep Learning Stock Forecast for Investors - Newser
Applying Elliott Wave Theory to Leap Therapeutics Inc.Trend Confirmation Scanner with Entry Focus - Newser
Top chart patterns to watch in Leap Therapeutics Inc.Free Reliable Chart-Based Trade Entries - Newser
What data driven models say about Leap Therapeutics Inc.’s futureInstitutional Holding Behavior Pattern Analysis - Newser
Leap Therapeutics Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingConsistent Return Setup with Exit Strategy - Newser
What’s next for Leap Therapeutics Inc. stock priceDaily Stock Forecast Powered by AI Tools - Newser
How Leap Therapeutics Inc. stock performs during market volatilityStock Portfolio Risk and Return Analysis - Newser
How to recover losses in Leap Therapeutics Inc. stockMachine Learning Stock Movement Detector - Newser
How hedge fund analytics apply to Leap Therapeutics Inc. stockEquity Portfolio Outlook and Performance Summary - Newser
How to integrate Leap Therapeutics Inc. into portfolio analysis toolsStable Profit Zone and Loss Control Analysis - Newser
Leap Therapeutics (LPTX) to Release Quarterly Earnings on Monday - Defense World
What machine learning models say about Leap Therapeutics Inc.Free Access to Smart Investment Tips - Newser
How to monitor Leap Therapeutics Inc. with trend dashboardsROI Prediction from Long-Term Holding Plans - Newser
Pattern recognition hints at Leap Therapeutics Inc. upsideRapid Trade Forecast Based on Indicators - Newser
Leap Therapeutics LPTX 2025Q2 Earnings Preview Downside Concerns Amid Lack of Revenue Visibility - AInvest
Relative strength of Leap Therapeutics Inc. in sector analysisAsset Allocation Summary With Future Outlook - Newser
What earnings revisions data tells us about Leap Therapeutics Inc.Free Stable Entry High Return Opportunities - Newser
Sector ETF performance correlation with Leap Therapeutics Inc.Fundamental Analysis for Value Stock Selection - Newser
Does Leap Therapeutics Inc. qualify in momentum factor screeningFree AI Trading Suggestions With Accuracy Focus - Newser
Will Leap Therapeutics Inc. stock recover after recent dropRSI and MACD Signal Summary with Trends - Newser
What makes Leap Therapeutics Inc. stock price move sharplyCapital Safe Picks with Consistent Gains - Newser
Real time alert setup for Leap Therapeutics Inc. performanceStock Market Watch with Smart Filters - Newser
Analyzing Leap Therapeutics Inc. with multi timeframe chartsFree AI-Powered Trade Planning with Indicators - Newser
Layoff Tracker: Sirona Liquidates TFChem, Merck Will Cut 6,000 Employees - BioSpace
Leap Therapeutics (LPTX.O) Sees Sharp Intraday Drop: What's Behind the Move? - AInvest
Leap Therapeutics Inc: Analyzing LPTX Stock Trends - investchronicle.com
Will earnings trigger a reversal in Leap Therapeutics Inc.Free AI Driven Stock Trend Forecast - Newser
Sentiment Tools Show Shift in Trader Mood on Leap Therapeutics Inc.Exit Ready Momentum Stock Watchlist Expanded - metal.it
Why is Leap Therapeutics Inc. stock attracting strong analyst attentionFree Stock Index Interpretation - Jammu Links News
What is the dividend policy of Leap Therapeutics Inc. stockMaximize returns with strategic portfolio planning - Jammu Links News
Is Leap Therapeutics Inc. a growth stock or a value stockTrack top-performing stocks effortlessly - Jammu Links News
Is Leap Therapeutics Inc. a good long term investmentAmplify your gains with low-risk picks - Jammu Links News
Should I hold or sell Leap Therapeutics Inc. stock in 2025Discover stocks with explosive potential - Jammu Links News
What are Leap Therapeutics Inc. company’s key revenue driversPhenomenal capital gains - Jammu Links News
What is Leap Therapeutics Inc. company’s growth strategyMaximize gains with data-driven trading alerts - Jammu Links News
What are the latest earnings results for Leap Therapeutics Inc.Invest confidently with data-driven strategies - Jammu Links News
Predicting Leap Therapeutics Inc. trend using moving averagesFree Growth Based Stock Signal Screener - newser.com
How does Leap Therapeutics Inc. compare to its industry peersExpert guidance for superior capital growth - Jammu Links News
립 테라퓨틱스 (LPTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):